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1. Introduction 
Infertility is a worldwide health problem with one in six couples suffering from this 
condition and with a major economic burden on the global healthcare industry. Estimates of 
the current global infertility rate suggest that 15% of couples are infertile (Zegers-
Hochschild et al., 2009) defined as: (1) failure to conceive after one year  of unprotected 
sexual intercourse (i.e. infertility); (2) continual failure of  implantation at subsequent cycles 
of assisted reproductive technology; or (3) persistent miscarriage events without difficulty 
conceiving (natural conceptions). Tubal factor infertility is among the leading causes of 
female factor infertility accounting for 7-9.8% of all female factor infertilities.  Tubal disease 
directly causes from 36% to 85% of all cases of female factor infertility in developed and 
developing nations respectively and is associated with polymicrobial aetiologies. One of the 
leading global causes of tubal factor infertility is thought to be symptomatic (and 
asymptomatic in up to 70% cases) infection of the female reproductive tract with the 
sexually transmitted pathogen, Chlamydia trachomatis. Infection-related damage to the 
Fallopian tubes caused by Chlamydia accounts for more than 70% of cases of infertility in 
women from developing nations such as sub-Saharan Africa (Sharma et al., 2009). Bacterial 
vaginosis, a condition associated with increased transmission of sexually transmitted 
infections including those caused by Neisseria gonorrhoeae and Mycoplasma genitalium is 
present in two thirds of women with pelvic inflammatory disease (PID). This review will 
focus on (1) the polymicrobial aetiologies of tubal factor infertility and (2) studies involved 
in screening for, and treatment and control of, Chlamydial infection to prevent PID and the 
associated sequelae of Fallopian tube inflammation that may lead to infertility and ectopic 
pregnancy.  
2. Tubal factor infertility   
In the absence of functional Fallopian tubes, couples may only conceive through in vitro 
fertilisation procedures. Women with tubal factor infertility may be defined as women who 
have either (1) damaged/occluded Fallopian tubes or (2) have history of salpingectomy. 
Ectopic pregnancy is only relevant if the Fallopian tubes remain in situ. Previous studies 
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have concluded that salpingitis can accompany early intrauterine pregnancy, often with 
significant foetal loss (Lara-Torre & Pinkerton 2002; Yip et al., 1993) but that upper genital 
tract infections do not always result in poor reproductive health outcomes (den Hartog et al., 
2006). PID, which is diagnosed in greater than 800,000 women each year in the United States 
is associated with Fallopian tube inflammation, which can lead to tubal factor infertility in 
women ranging from 5.8% and 60%, depending upon the microbial aetiology of disease and 
the number of recurrent infections (Soper, 2010; Westrom, 1980).  A recent estimate, not 
including women with ‘silent salpingitis’ or asymptomatic infections was that the annual 
cost of caring for women with PID is US $2 billion (Soper, 2010). PID is known to be caused 
by the sexually transmitted microorganisms C. trachomatis, N. gonorrhoeae, and M. genitalium 
as well as bacterial vaginosis-associated microorganisms consisting predominantly of 
anaerobic Gram-negative bacilli. Investigations into the levels of antimicrobial compounds 
in Fallopian tubes or antibodies in sera collected from women with ectopic pregnancy, 
suggest that immune responses to infectious agents may also predispose for this condition 
(Refaat et al., 2009; Srivastava et al., 2008).  
3. Fallopian tube function  
The Fallopian tube plays an essential role in gamete and zygote transport. In parallel with 
the endometrium, the Fallopian tube also undergoes cyclical changes in response to the 
steroid hormones oestradiol and progesterone, which alter morphology and the frequency 
of beating of the ciliary (Critoph and Dennis, 1977a).  
The transport of gametes and embryos through the Fallopian tubes relies on contractions of 
the tubal musculature, ciliary activity and the flow of tubal secretions (Jansen, 1984). 
Distortions of the luminal architecture of the Fallopian tubes have been associated with 
tubal ectopic pregnancy, predominantly because of failure of the transport mechanisms to 
move the gametes/embryos through the tube and into the uterus prior to implantation 
(Mast, 1999). Microbial infection of the Fallopian tubes is one reason for alterations in the 
tubal epithelial lining. Tubal disease resulting in infertility is the result of an inflammatory 
process in or around the Fallopian tube (Mastroianni, 1999). The extent of tubal damage is 
dependent on the severity and duration of the infection. The disease spectrum ranges from 
complete tubal occlusion with hydrosalpinx to mild intraluminal adhesions (Mastroianni, 
1999).   
3.1 Ovulation and oocyte capture  
After ovulation, follicular fluid is the major constituent of the Fallopian tube secretions. The 
overall composition and viscosity of the tubal secretions (including elevated levels of steroid 
hormones and prostaglandins) enhances the ciliary beat frequency (Blandau et al., 1975). 
Ciliary beat frequency is different for each part of the Fallopian tube. Elevations in the 
progesterone concentration in tubal secretions result in a slowing of the ciliary beat to allow 
fertilisation to occur, however, if the progesterone levels are too high then deciliation occurs 
and the prolonged delay in ciliary beat may result in implantation of the embryo within the 
Fallopian tube mucosa (Diaz et al., 1980).  
Prostaglandins within the follicular fluid mix with the tubal secretions and also increase the 
contractility of the fimbriae and the tubo-ovarian ligaments (Morikawa et al., 1980). A 
controlled, deliberate movement of the tubal fimbriae ensues, initiating contact between the 
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point of ovulation and the cumulus-oocyte-complex gently propelling the ovulated oocyte 
into the Fallopian tube toward the uterus (Lindblom & Andersson 1985). Transportation of 
the oocyte and then following fertilisation, the embryo, through the Fallopian tubes takes 
approximately 80 hours (Croxatto et al., 1972; Croxatto et al., 1978). Inhibition of oocyte 
capture by the Fallopian tube may result from microbial infections of the tube. The 
subsequent immune response can form adhesions on the fimbrial end of the Fallopian tubes 
or cause altered pelvic anatomy, which prevents the physical movement of the tube.  
3.2 Steroid hormones (oestradiol and progesterone)  
The Fallopian tubes undergo cyclical changes under the influence of the steroid hormones, 
oestradiol and progesterone (Critoph & Dennis, 1977) and Fallopian tube steroid hormone 
receptors are expressed in response to the ovulatory cycle (Pollow et al., 1981). Changes in 
the steroid hormone expression within the Fallopian tube contribute to successful transport 
and ultimately implantation (Horne et al., 2009).  
Progesterone has an inhibitory effect in ciliary movement and tubal smooth muscle 
contractility, resulting in a reduction in contraction frequency (Paltieli et al., 2000) and ciliary 
beat (Wanggren et al., 2008), capable of causing delayed transport of the embryo and ectopic 
implantation. Horne et al., (2009) reported a reduced expression of progesterone receptors in 
the Fallopian tubes of women with previous tubal ectopic pregnancies. They were also 
unable to detect expression of an oestrogen receptor on the Fallopian tubes from these same 
women when compared to Fallopian tubes from non-pregnant women. The alterations in 
steroid hormone expression in response to the ovulatory cycle were discordant in non-
pregnant women, compared with those reported in women with tubal ectopic pregnancies 
(Horne et al., 2009).  
The oestrogen receptor is reportedly a dominant regulator of normal Fallopian tube 
development (Mowa & Iwanaga 2000) however; expression of the oestrogen receptor 
remains constant throughout the ovulatory cycle (Horne et al., 2009).  
Previous investigations have assessed the effect of oral contraceptives on the risk of ectopic 
pregnancy. The inhibition of fertilisation or ovulation resulted in a decreased incidence of 
ectopic pregnancy in women with vasectomised male partners, and in women prescribed 
combined oral contraceptives. In contrast, the incidence of ectopic pregnancy was elevated 
in women using progesterone only contraceptives, and highest in those women using 
progesterone only contraceptive and an intra-uterine device (Franks et al., 1990). This may 
be due to the effect of progesterone on ciliary beat frequency or in the case of an intra-
uterine device; there is an increased risk of ascending infection by commensal microflora. 
Finally, the steroid hormones oestradiol and progesterone are growth factors or inhibitors 
for various microbial species. It has been suggested that the more frequent diagnosis of 
specific genital tract infections at various stages of the menstrual cycle is due to the 
concentrations of each of these hormones (Sonnex, 1998). 
3.3 Salpingitis and alterations to the Fallopian tube luminal epithelium  
The most frequent cause of ectopic pregnancy is previous salpingitis (Lehner et al., 2000). 
The predominant facultative pathogens identified in tubal fluid from women with 
salpingitis are coliform bacteria (Holmes et al., 1980; Ledger et al., 1994; Swenson et al., 1974) 
and the predominant anaerobic species originate from the Bacteroides genera. 
Microorganisms and the immune response may result in scar tissue formation, alter the 
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activity of tubal cilia, result in the partial or complete destruction of cilia, and alter the 
composition and viscosity of the tubal secretions. Within the Fallopian tube mucosa, the 
response to microorganisms is not uniform. Each species evokes an individual and specific 
response (Laufer et al., 1984). For example, E. coli cells or lipopolysaccharide cause swelling 
of the ciliary tips followed by adhesions between shortened and swollen cilia in addition to 
shortened microvilli on non-ciliated cells (Laufer et al., 1980; Laufer et al., 1984). C. 
trachomatis infection of Fallopian tubes reveals patches of flattened cells mixed with cells 
with only a single elongated cilium (Patten et al., 1990). The sexually transmitted pathogen, 
N. gonorrhoeae causes invagination in ciliated cells and loss of microvilli in non-ciliated cells 
(Draper et al., 1980).  
4. Effects of microorganisms on the Fallopian tubes  
The Fallopian tubes play an integral role in reproduction and undergo cyclical changes in 
morphology and ciliary activity that are dependent upon ovarian hormones (Lyons et al., 
2006). Recent reviews have reported that infection reduces ciliary motion and even destroys 
cilia within the Fallopian tubes (Lyons et al., 2006; Shaw et al., 2010). Reduced ciliary 
function can be a cause of infertility and can result in ectopic pregnancy since the embryo 
relies on cilia to facilitate its propulsion through the Fallopian tubes into the uterus. In 
addition, inflammation of the lumen of the Fallopian tubes results in tubal occlusion and 
tubal factor infertility. Whilst much research regarding the microflora associated with 
Fallopian tube damage continues to focus on sexually transmitted pathogens many other 
microorganisms have been associated with Fallopian tube pathology and tubal factor 
infertility. 
4.1 Bacterial vaginosis   
Bacterial vaginosis is a frequently encountered condition among women affecting from 
between 10 – 20% of fertile women (Holmes, 2008). Bacterial vaginosis is induced by the 
change from Lactobacillus spp. dominant vaginal flora to vaginal flora dominated by other 
microorganisms (Holmes, 2008). Several factors contribute to a reduction in the vaginal 
Lactobacillus spp. levels including antimicrobial treatment, hormonal imbalance, douching, 
use of non-barrier contraception, demographic factors − age and socioeconomic status, and 
the sexual history of the female − age of commencement of sexual intercourse, and number 
of previous sexual partners (Tibaldi et al., 2009; Witkin et al., 2007a). Bacterial vaginosis is a 
polymicrobial condition and an altered immunity hypothesis proposes that bacterial vaginosis 
develops as a result of the inhibition of Toll-like receptor (TLR) activation. The negative 
consequences of bacterial vaginosis are facilitated in part by a release and/or inadequate 
function of the antimicrobial plasma protein, mannose binding lectin (MBL) (Witkin et al., 
2007b).  Microorganisms that frequently replace the normal Lactobacillus dominant lower 
genital tract flora include Gardnerella vaginalis, Ureaplasma spp., M. hominis, Streptococcus 
viridans and anaerobic Gram-negative bacilli from the genera Prevotella, Porphyromonas, 
Bacteroides, Fusobacterium and the coccus, Peptostreptococcus (Biagi et al., 2009; Hillier 1993). The 
quantification of several microorganisms, particularly G. vaginalis and Atopobium vaginae, 
allows for a molecular diagnosis of bacterial vaginosis (Menard et al., 2008).  Microorganisms 
infecting the lower genital tract can be transported to the uterus and the Fallopian tubes either 
by (1) ascending to cause endometritis and subsequent salpingitis or (2) transport by the 
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lymphatic system (Brook, 2002). Bacterial vaginosis has been associated with genital and 
obstetric infections, including PID (Catlin, 1992; Hay et al., 1992; Soper, 1994), particularly in 
the presence of other sexually transmitted infections (Hillier et al., 1996; Wiesenfeld et al., 2002) 
including human papilloma virus infections (Verteramo et al., 2009).  
Gaudoin et al., (Gaudoin et al., 1999) reported a strong association between bacterial 
vaginosis and tubal factor infertility and in a study by Wilson and colleagues (2002) it was 
concluded that women with tubal infertility were three times more likely to have bacterial 
vaginosis than women with male factor or unexplained infertility.  In a retrospective 
analysis of a population of 952 women investigated over two years, it was recently reported 
that the genital discharges of asymptomatic women with infertility consisted of an 
overgrowth of several aerobic bacteria especially G. vaginalis (19.7%), Enterobacteriaceae or 
Enterococci (12.1%) and Streptococcus agalactiae (8.6%) noting a prevalence of C. trachomatis of 
only 0.5% in this cohort of women (Casari et al., 2010).  
4.2 Upper genital tract infections   
The most frequent method of female upper genital tract infection is by ascension of 
members of the lower genital tract endogenous microflora, which may first cause disruption 
to the normal balance such as that seen in cases of bacterial vaginosis or vaginal candidiasis 
(Population Council, 2003). Following medical intervention, iatrogenic infections may result 
from the direct inoculation of microorganisms from the lower genital tract into the upper 
genital tract. Iatrogenic procedures associated with tubal ectopic pregnancy are tubal 
surgery and trans-vaginal oocyte retrieval for in vitro fertilisation (IVF).  
Seminal fluid is also reportedly a mechanism of microbial transfer to the female upper 
genital tract. Furthermore, some microorganisms have the propensity to attach to the surface 
of spermatozoa, whilst others are obligate intracellular parasites within the spermatozoa C. 
trachomatis, N. gonorrhoeae, Mycoplasma spp., Ureaplasma spp., and E. coli have all been shown 
to adhere to the surface of spermatozoa or form intracellular inclusions within the 
spermatozoa (Friberg et al., 1987; Hickey et al., 2009; James-Holmquest et al., 1974; Murthy et 
al., 2009; Sanchez et al., 1989; Wolner-Hanssen & Mardh 1984). Further, female partners of 
infected men with spermatozoa in their ejaculate had a significantly higher incidence of 
upper genital tract infection compared to infected men who have been vasectomised (Toth et 
al., 1984). Interestingly it was recently reported that a significantly higher incidence of 
sperm-immobilizing antibodies (6.4%) was found in sera collected from 273 infertile women 
with a past C. trachomatis infection compared to that found in women without a past 
chlamydial infection (1.5%) (Hirano & Hoshino 2010).  Thus, it may be that the production 
of sperm-immobilizing antibodies in infertile women is the result of a past C. trachomatis 
infection in these women and this may contribute to their infertility. 
4.3 Infections of the female upper genital tract (the endometrium, Fallopian tubes and 
ovaries)    
It is becoming increasingly accepted that the female upper genital tract is not a sterile site,  
but likely in fact to be asymptomatically colonised or infected with  microorganisms (Horne 
et al 2008; Wira et al 2005). Endometritis, a persistent inflammation of the endometrial 
lining, has been reported in up to 19% of women (Farooki 1967). Endometritis is frequently 
asymptomatic, but similarly to other gynaecological infections, endometritis has been 
shown to reduce conception rates (Feghali et al 2003; Taylor & Frydman 1996). Excessive 
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inflammation in the endometrium at the time of implantation may be a cause of infertility. 
Endometritis represents an early stage in the continuum from lower genital tract infection 
through to salpingitis, the most serious form of female genital tract infection with respect to 
fertility.  
Endometritis is a polymicrobial infection caused by the ascension of endogenous 
microorganisms or sexually transmitted infections. Endometritis is frequently reported in 
association with an altered lower genital tract microflora, such as that seen in women with 
bacteria vaginosis (Hillier et al., 1992; (Jacobsson et al 2002) or PID (Centres for Disease 
Control and Prevention, 2002). Alterations of the lower genital tract microbial milieu are not 
the only cause of endometiritis as this infection has been reported in women with ‘normal’ 
levels of lower genital tract microorganisms (Lucisano et al 1992). Microorganisms can also 
be introduced into the endometrium iatrogenically, during gynaecological investigations 
and treatment (Kiviat et al 1990). 
PID results from ascension of microorganisms from the vagina to the upper genital tract 
(Holmes, 1984) causing post-infectious inflammation with potentially long-term sequelae 
including tubal infertility, ectopic pregnancy and pelvic pain (Cherpes et al., 2006). 
Reportedly, up to 20% of women will be rendered infertile following a single diagnosis of 
PID (Westrom et al., 1992) increasing to 50% following multiple episodes (Westrom et al., 
1980). In addition, women with a history of PID were twice as likely to have experienced an 
ectopic pregnancy when compared to women without any history of upper genital tract 
infection (Miller et al., 1999). Similar to bacterial vaginosis, PID is also frequently 
polymicrobial. Opportunistic pathogens comprising anaerobic and facultative aerobic 
bacteria from the normal microflora of the lower genital tract, or species implicated in 
genital tract infections cause up to 50 % of PID, not the sexually transmitted bacteria C. 
trachomatis or N. gonorrhoeae (Soper, 2010).  
Salpingitis is an infection in the Fallopian tube(s). A polymicrobial microflora has been 
reported for Fallopian tube tissue from women with salpingitis (Eschenbach et al., 1975; 
Soper, 1994). Tubo-ovarian abscesses represent an extension of salpingitis and reportedly 
occur in up to 16% of women diagnosed with salpingitis. 
Tubo-ovarian abscesses are usually complications of PID and represent inflammation of 
both the Fallopian tubes and the ovaries (Landers & Sweet 1983). The microbial aetiology of 
tubo-ovarian abscesses is predominantly polymicrobial (Landers & Sweet 1983; Wiesenfeld 
& Sweet 1993). Microbial invasion of the Fallopian tube(s) initiates an inflammatory 
response which results in oedema, increased pressure and restricted blood supply to the 
affected Fallopian tube(s) causing abscess formation and survival of the pathogens in a 
‘protected’ environment (Osborne, 1986). 
Numerous sexually transmitted and non-sexually transmitted pathogens have been isolated 
from infected upper genital tract tissues. Bacterial vaginosis associated bacteria have been 
detected independently of C. trachomatis and/or N. gonorrhoeae suggesting that 
investigations regarding causes of upper genital tract infection, but more specifically in the 
context of tubal ectopic pregnancy, and tubal damage, should focus on a diverse range of 
microorganisms. 
4.4 Chlamydia trachomatis 
C. trachomatis is an important pathogen in the aetiology of acute PID and has been isolated 
from the upper genital tracts of approximately one quarter of patients with this disease. In 
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addition to causing symptomatic PID, C. trachomatis is also associated with subclinical upper 
genital tract disease in women (Horne et al., 2008). The potentially serious sequelae of 
cervical infection with C. trachomatis can include infertility, ectopic pregnancy, pelvic pain 
and recurrent PID and these have recently been reviewed (Batteiger et al., 2010; Darville and 
Hiltke, 2010; Haggerty et al., 2010;). The extent to which disease sequelae eventuate 
following cervical infection with C. trachomatis is probably also significantly linked to 
natural processes that occur in the reproductive tract and include coitus-related phenomena 
and cyclical hormonal conditions. A novel paradigm that includes consideration of these 
and other aspects of reproductive biology particularly when using animal models to 
investigate potential vaccines for chlamydial genital tract infections in women has recently 
been proposed (Lyons et al., 2009a). Continued investigations into the mechanisms of 
Chlamydia-induced tissue damage are required to further develop our understanding of the 
pathogenesis of genital tract disease caused by this organism, and to direct research into 
effective ways to control C. trachomatis infection, including vaccine development.  
4.4.1 Chlamydia, tubal pathology and tubal factor infertility 
In women it has previously been reported that a single chlamydial infection of the genital 
tract does not result in tubal scarring (Paavonen and Eggert-Kruse, 1999); however, 
prolonged exposure to Chlamydia due to a chronic persistent infection or frequent re-
infection has been associated with (1) an autoimmune response to Chlamydial heat shock 
protein (which shares homology with human heat shock protein) and (2) the chronic 
inflammation associated with tubal factor infertility (Brunham and Peeling, 1994; Mardh, 
2004; Ness et al., 2008). The severity of the inflammatory response to chlamydial infection is 
enhanced during re-infection, causing inflammation, tissue damage and scarring. Recent 
studies by Hvid et al., (2007) have concluded that damage to the Fallopian tubes is 
disproportional to the number of C. trachomatis infected cells, suggesting that Fallopian tube 
cell lysis does not occur as a direct result of infection. In their study, they instead 
demonstrated that IL-1 had a toxic effect on ciliated Fallopian tube cells.  
Based on the results of epidemiological studies, prospective data from studies of infertile 
women and on results from animal models, C. trachomatis infection of the female 
reproductive tract is known to be causally associated with tubal infertility. In the murine 
model, a primary chlamydial infection is sufficient to induce tubal damage and infertility 
(Swenson et al., 1983) with Toll-like receptor 2 being identified as essential for oviduct 
pathology in this model (Darville et al., 2003; Phillips et al., 1984;). Derbigney and colleagues 
(2007) reported that C. muridarum infection of murine oviduct epithelial cell lines induced a 
beta-interferon response and implicated Toll-like receptor 3 as the source of this interferon.  
In female guinea pigs, long-term tissue damage was also caused following the host response 
to a primary chlamydial infection (Rank and Sanders, 1992), with chlamydial salpingitis also 
reported in female guinea pigs receiving oral contraceptives (Barron et al., 1988). By contrast, 
in macaque monkeys a single upper genital tract infection with Chlamydia is usually self-
limiting with tubal scarring only resulting from repeated episodes of salpingitis (Patton et 
al., 1987; VanVoorhis et al., 1997). It has been shown that C. trachomatis infection in monkeys 
induced delayed hypersensitivity, which is proposed to be the pathogenic mechanism of 
tubal damage in this species (Patton et al., 1994).  
There have been reports of serologic evidence of past chlamydial infections (Ness and 
Brooks-Nelson, 1999; Patton et al., 1994b; Robertson et al., 1987) in women with tubal 
infertility, and it has been reported that interleukin-1 (IL-1) initiates Fallopian tube 
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destruction following a C. trachomatis infection (Hvid et al., 2007). In a retrospective study of 
84 infertile women with tubal occlusion, the sera collected from 28% of these women were 
positive for chlamydial anti-IgG antibody, compared to only 11% positivity to the 
chlamydial anti-IgG antibody in sera collected from 253 infertile controls (Merki-Feld et al., 
2007). A study of 114 women with laparoscopically-verified tubal factor infertility (of which 
96 cases showed evidence of past infection with Chlamydia) was undertaken to further 
elucidate the mechanisms of tubal damage in women with Chlamydia-associated infertility 
(Ohman et al., 2009).  The functional polymorphisms in selected cytokine genes [including 
IL-10, interferon gamma (IFN-Ǆ), tumour necrosis factor alpha (TNF-ǂ] revealed an increase 
in severe tubal damage in women with infertility caused by Chlamydia when certain IL-10 
and TNF-ǂ alleles were present (Ohman et al., 2009). In terms of cytokine secretions in 
Chlamydia-positive infertile women, it has been reported that Chlamydia-stimulated cervical 
cells secreted significantly higher levels of IL-1ß, IL-6, IL-8 and IL-10.  This indicated that the 
cytokine secretion profile of cervical cells may produce vital information to indicate the 
outcome (i.e. fertile or infertile) of a chlamydial infection of the female genital tract (Agrawal 
et al., 2009). Others have reported that IL-1ǃ, IL-4, IL-5 and IL-6 as well as IL-10 levels were 
found to be higher in Chlamydia membrane protein (Inc protein)-stimulated cervical cells  of 
C. trachomatis-positive infertile women compared to fertile women infected with Chlamydia 
(Gupta et al., 2009). More recently a unique link between elevated levels of anti-Chlamydial 
caseinolytic protease P (ClpP) and tubal factor infertility was identified in 21 tubal factor 
infertility patients (Rodgers et al., 2010). 
Host genetic factors are known to modulate the immune defence mechanisms to a Chlamydia 
infection thus determining the occurrence of Chlamydia-induced tubal factor infertility. A 
study by Morre and colleagues (2002) reported that almost 45% of women infected with 
genital chlamydial infections cleared the infection after one year with no interventional 
treatments. However, some authors have claimed that this study by Morre et al.,. (2002) was 
methodologically flawed (Risser and Risser, 2007; Simms and Horner, 2008).  An increased 
risk of tubal pathology (as a result of aberrant immune responses) has been reported in 227 
sub-fertile women following a C. trachomatis infection and carrying two or more single-
nucleotide polymorphisms (SNPs) in genes (toll-like receptor (TLR)-9, TLR-4, CD14, and 
caspase recruitment domain protein 15 (CARD15)/nucleotide-binding oligomerization 
domain containing 2(NOD2) that encode pattern recognition receptors (PRRs) involved in 
sensing bacterial components (den Hartog et al., 2006).  In a more recent report that 
investigated 214 infertile women, 42 of whom had tubal pathology, it was found that 
polymorphisms in the major histocompatibility complex class I chain related A gene 
(specifically allele 008) correlated with C. trachomatis anti-IgG antibodies in infertilewomen 
(Mei et al., 2009). 
4.4.2 Chlamydia and PID 
PID is caused by infection of the female genital tract with microorganisms including C. 
trachomatis (Bakken and Ghaderi, 2009) and testing for serum antibody to the chlamydial 
60kDa Heat shock protein  (i.e.CHSP60 antibody)  is an accurate means for predicting 
Chlamydia-associated tubal factor infertility (Claman et al., 1997). A prospective study into 
serologic parameters of tubal disease reported that antibodies to CHSP60 were also 
predictive for lower spontaneous conception and pregnancy outcome after a first episode of 
ectopic pregnancy (Sziller et al., 2008). A retrospective study of follicular fluid from 253 IVF 
patients for IgG antibodies to CHSP60 reported that antibodies to CHSP60 were found in 
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74.1% of women without embryo (s) and in 69.5% of women with tubal occlusion (Jakus  et 
al., 2008). In the PID evaluation and clinical health (PEACH) study 443 women with clinical 
signs of mild to moderate PID were followed for 84 months and assessed for long-term 
sequelae of chlamydial infections of the genital tract including PID recurrence and time to 
pregnancy (Ness et al., 2008). It was found that IgG antibody responses to CHSP60 and 
elementary bodies (the extracellular form) of C. trachomatis serovar D were independently 
associated with reduced pregnancy rates and increased rates of recurrent PID (Ness et al., 
2008). In another study of 72 female patients a significant seropositivity to CHSP60 
antibodies was detected in patients with secondary infertility from an infertile cohort 
clinically characterised primary and/or secondary infertility. This indicated that specific 
antibodies to CHSP60 may aid in the early prognosis of immunopathologic sequelae 
following genital tract infections with C. trachomatis (Dutta et al., 2008). The 10kDa 
chlamydial heat shock protein 10 (CHSP10) has also been identified as a target of cell-
mediated responses in human chlamydial infections. Women with tubal infertility have 
been shown to recognise CHSP10 more frequently than those women with current active 
chlamydial infections. Co-expression of both CHSP60 and CHSP10 were subsequently 
detected at higher levels in the infertile women compared to the fertile women (Jha et al., 
2009). CHSP10 and CHSP60 stimulation was reported to increase the cytokine responses of 
IFN-Ǆ and IL-10 in Chlamydia-positive infertile women (Srivastava et al., 2008). Srivastava et 
al.,. (2008) suggested that this could significantly affect the release of these cytokines from 
the cervical mononuclear cells, thus affecting the mucosal immune function against this 
pathogen and hence fertility outcomes in these women. 
Linhares and Witkin (2010) recently reviewed the immunopathogenic consequences of 
CHSP60 expression in the female genital tract and they reported that scar formation and 
tubal occlusion resulted from the induction of pro-inflammatory immune responses 
following the release of CHSP60 from a C. trachomatis infection. They further reported that 
the production of CHSP60 cross-reacting antibodies and cell-mediated immunity to the 
human HSP60 was detrimental to subsequent pregnancy outcome in women infected in the 
upper reproductive tract with this microbial pathogen (Linhares and Witkin 2010).   
4.4.3 Chlamydia screening 
Screening for, and treatment of, chlamydial infection is aimed at reducing chlamydial 
transmission and preventing PID and the long-term sequelae of PID including infertility, 
chronic pain, recurrent episodes of PID and ectopic pregnancy. 
For the host to successfully clear infections of the female genital tract caused by C. 
trachomatis an adequate immune response is required following recognition of the pathogen 
by pattern recognition receptors (PRRs) of the Toll-like receptor (TLR) and nucleotide 
binding oligomerization domain (NOD) families. If functioning correctly, the host immune 
response clears the infection but in some females the infection is not cleared and this allows 
for a persistent infection to manifest in these hosts. Since most infections with Chlamydia 
remain asymptomatic it is difficult to ascertain the risk of potential disease sequelae 
associated with previous chlamydial infections. There are several methods used to assess the 
risk of chlamydial infections in women that may lead to tubal factor sub-fertility and these 
have been reviewed (den Hartog et al., 2006). In particular it has been found that testing for 
anti-chlamydial IgG antibody in serum can indicate a previous infection but cannot predict a 
persistent infection. It has been noted that screening for serological markers of persistence 
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(including C-reactive protein) seems useful for identifying infected women at highest risk of 
tubal pathology. It has been proposed that three screening strategies would be useful for 
identifying tubal factor sub-fertility in women infected in the genital tract with C. 
trachomatis: (1) C. trachomatis IgG antibody testing, (2) high sensitivity CRP testing and (3) 
hysterosalpingography (den Hartog, 2008). A recent mathematical modelling study has 
analysed previously published data on the persistence of asymptomatic C. trachomatis 
infection in women, and has estimated the mean duration of the asymptomatic period to be 
longer (433 days) than previously anticipated. These authors conclude that their study 
shows that a longer duration of the asymptomatic period results in a more pronounced 
impact of a screening programme (Althaus et al., 2010). 
The incidence of PID in untreated women infected with C. trachomatis has been reviewed and 
widely discussed in the literature in terms of (1) its cost-effectiveness as a screening program 
and (2) as a predictor of tubal damage in infertile patients (Aghaizu et al., 2008; Althaus et al., 
2010; Bakken & Ghaderi 2009; den Hartog et al., 2008; Dietrich et al., 2010; Kalwij et al., 2010; 
Land et al., 2010; Low et al., 2009; Low & Hocking 2010; Oakeshott et al., 2010; Risser & Risser 
2007; Simms & Horner 2008).  In a comprehensive study that evaluated all available original 
research and  assessed the incidence of PID following C. trachomatis infection, it was concluded 
that no study could adequately answer the question and that many studies either had 
inaccuracies, validition problems or only indirect evidence to support their reported 
incidences (Risser and Risser, 2007). A similar review of the literature was undertaken by 
Simms and Horner (2008) who stated that a reasonable estimate of PID incidence in untreated 
women after C. trachomatis infection was likely to be in the range of 10-20%.  A Norwegian 
registry-linkage study of 24,947 women who were tested for C. trachomatis infection reported a 
correlation between diagnosed Chlamydia infection and subsequent PID. The incidence rate of 
PID in this study was found to be higher in women with prior C. trachomatis infection than 
among women with negative C. trachomatis tests although the rates were notably low in both 
groups (Bakken & Ghaderi 2009). It has therefore been suggested that the benefits of current 
Chlamydia screening programmes may have been overestimated (Low et al., 2006).   
A comprehensive review of seven electronic databases covering 17 years of register-based 
reports (until 2007) and opportunistic screening programmes for Chlamydia found that there 
was no evidence to support the most commonly recommended approach of opportunistic 
Chlamydia screening in a general population younger than 25 years. Furthermore, it was 
proposed by these authors that an effective approach when assessing biological outcomes of 
chlamydial infection currently reuqires multiple rounds of screening in randomized control 
trials (RCT) (Low et al., 2009). A recent RCT (the POPI-prevention of pelvic infection-trial) was 
undertaken to determine whether a single screening test and treating a subset of 2529 women 
for chlamydial infection can in fact reduce the incidence of PID over a 12-month period 
(Oakeshott et al., 2010). The baseline prevalence of Chlamydia was 5.4% in the screened 
population of 2529 sexually active female students (mean age 20.9 years) and 5.9% in (deferred 
screening) controls with the incidences of PID found to be 1.3% and 1.9% respectively in these 
cohorts.  It was reported that after 12 months, most episodes of PID occurred in women who 
tested negative for Chlamydia at baseline (9.5%) when compared to the intervention group 
(1.6%) and these authors concluded that the effectiveness of a single Chlamydia test in 
preventing PID over 12 months may also have been overestimated (Oakeshott et al., 2010).  
A Danish randomised trial was conducted with 9-year follow-up testing of 4000 asymptomatic 
women for the presence of urogenital Chlamydia trachomatis. Data were collected on PID, ectopic 
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pregnancy EP, infertility diagnoses, IVF treatment and births in women.  Results showed that no 
differences were found between the intervention group and the control groups of women for 
PID, ectopic pregnancy, infertility, IVF treatment and births.  It was concluded that a population-
based offer to be tested for urogenital C. trachomatis infection using non-invasive samples and 
DNA amplification testing did not reduce the long-term risk of reproductive complications such 
as PID and ectopic pregnancies in asymptomatic women (Anderson et al., 2011). This finding 
agrees with the conclusions made by authors of an earlier review of 12 databases who reported 
(from the one study that satisfied inclusion criteria for their review) the absence of valid evidence 
on the risk of tubal factor infertility following an infection of the genital tract with C. trachomatis 
(Wallace et al., 2008) and is also in agreement with the finding of Oakeshott and colleagues 
(Oakeshott et al., 2010). 
Of note from the Oakeshott study was that a screening intervention at 12 months would not 
have prevented the 10 reported cases of chlamydia-positive PID among women who were 
Chlamydia-negative at baseline and serves to highlight the ongoing transmission of 
Chlamydia as the elemental problem. The results of the POPI trial suggested that current 
levels of chlamydial screening are unlikely to have much impact on the overall incidence of 
PID (Low & Hocking 2010). A recent modelling study based on a comprehensive literature 
survey on the epidemiology of chlamydial infection and risk-estimates of its late 
complications has concluded that the risk of developing tubal infertility after a Chlamydia 
lower genital tract is low (at around 4.6%), and these authors stated that high quality RCTs 
investigating the transition from cervicitis to tubal infertility are needed (Land et al., 2010).  
It has also been reported in a prospective study evaluating the sensitivity of multiple-site 
swab testing (cervix, urethra, vagina and Fallopian tubes) in 2,020 fertility patients over 12 
months that multiple site sampling does not increase the detection rate of C. trachomatis 
among infertile women and in fact that routine DNA testing for C. trachomatis should be 
confined to cervical sampling (Dietrich et al., 2010).  A review from the National Chlamydia 
screening programme in London has highlighted the need for Chlamydia testing to be 
offered routinely to young people (under 25 years) as part of an overall approach to sexual 
health in the community (Kalwij et al., 2010). 
It has been noted recently that no studies have yet published results of the effects of greater 
than one round of screening or indeed screening for repeat Chlamydia infections on 
reproductive sequelae in women following asymptomatic C. trachomatis genital infection 
(Gottlieb et al., 2010).  However two new trials the Chlamydia Screening Implementation 
(CSI) Project (van den Broek et al., 2010) and the Australian Chlamydia Control Effectiveness 
Pilot (ACCEPt) trial (Hocking et al., 2008) are currently underway investigating multiple 
screening rounds and using Chlamydia prevalence (and not PID) as the end point. These 
trials should provide more conclusive information regarding the effectiveness of chlamydial 
screening to control morbidity associated with genital chlamydial infection. 
4.4.4 Chlamydia and vaccines 
Fertility in women is overwhelmingly affected by unresolved or untreated infection of the 
female reproductive tract with C. trachomatis.  Since greater than 70% of chlamydial genital 
infections in women are asymptomatic and sequelae of infection manifest as diseases 
resulting from severe pathological consequences such as tubal occlusion, a vaccine is likely 
to be imperative to control infections caused by this sexually transmitted mucosal pathogen. 
Many animal models of infection-induced immunity including murine and guinea pig 
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models continue to be essential in providing knowledge of the infection processes and 
immune responses to a variety species found within the Chlamydiaceae. These have 
recently been reviewed by several groups (Cochrane et al., 2010; Farris & Morrison 2011; 
Hafner et al., 2008; Hafner 2007; Hafner & McNeilly 2008; Lyons et al., 2006; Miyairi et al., 
2010; Rank & Whittum-Hudson 2010). These animal models have proved invaluable in 
providing knowledge of many novel candidate antigens for a vaccine (Barker et al., 2008; 
McNeilly et al., 2007; Murthy AK et al., 2011; Murthy et al., 2009) as well as novel delivery 
vehicles (Xu et al., 2011) and delivery routes such as oral and transcutaneous immunization 
for protection of genital infections (Hickey et al., 2010; Hickey et al., 2009) and have 
investigated a myriad of potential adjuvants (reviewed in Cochrane et al., 2010; Farris and 
Morrison, 2011; Hafner et al., 2008) and immune responses elicited following animal 
immunization trials (Cunningham et al., 2011; McNeilly et al., 2007; Patton et al., 1983). For 
example it has recently been reported that a Vibrio cholerae ghost (VCG) multisubunit 
chlamydial vaccine delivered to mice by the intramuscular route stimulated immune 
memory in these animals (Eko et al., 2011). Protection correlates that have been assessed in 
these models to determine vaccine efficiency have included reduced shedding of viable 
chlamydial infectious bodies, reduced duration of infection and reduced tissue pathologies 
such as hydrosalpinx; a vaccine that can achieve one and/or any of these outcomes will 
greatly aid in diminishing the pathological sequelae of chlamydial genital infections. 
Results of recent studies using animal models have revealed many promising novel 
candidate antigens for eliciting protection against chlamydial genital tract infections in 
humans. The fusion protein CTH1 is composed of chlamydial proteins from two highly 
conserved (>97% homology) immune-dominant antigens CT443 (omcB) and CT521 (r116) 
that are targets both for cell-mediated and for humoral immunity and thus can be expected 
to allow for cross-protection amongst the various chlamydial serotypes (Olsen AW et al., 
2010). In addition, CT 521 has also been found to be a strong and frequent target for T cells 
during a natural C. trachomatis infection in humans (Olsen et al., 2006).  In 2009 a study 
investigating 55 chlamydial ORFs covering all putative type III secretion components and 
control molecules were expressed as fusion proteins. This study measured the reactivity of 
these fusion proteins with antibodies from sera collected from patient infected with C. 
trachomatis in the urogenital tract (24 antisera) (Wang et al., 2009).   It was reported that 
immunization of mice with the translocated actin recruiting phosphoprotein (Tarp) induced 
Th1-dominant immunity that significantly reduced the shedding of live bacteria from the 
lower genital tract and attenuated inflammatory pathologies in the Fallopian tube tissues 
(Wang et al., 2009).  Using the C3H/HeN murine model the subunit vaccine CtH1 delivered 
subcutaneously with a Th1-inducing adjuvant (CAF01) induced a protective CD4+T cell 
response and high levels of CTH1-specific antibodies in both the sera and genital tracts of 
immunised mice however it failed to provide a CD4 independent protective response 
needed for complete protection (Olsen et al., 2010). A second promising vaccine candidate 
that has induced CD4+Th1 cells both in Chlamydia-infected mice and in humans diagnosed 
with chlamydial genital tract infections is CT043 a highly conserved hypothetical protein 
that could potentially provide cross-serotype protection. DNA priming/protein boost 
immunization with this protein the bacterial load was also significantly reduced in the 
murine lung infection model (Meoni et al., 2009).  The fact that CTD43 has been shown to 
reduce (1) chlamydial infectivity in the murine model and (2) to prime a CD4+Th1 response 
in over 60% of patients infected with genital serovars of C. trachomatis, means that this 
antigen could be a promising vaccine candidate for chlamydial genital tract infections. A 
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third candidate antigen showing great promise particularly for prevention of infertility 
resulting from repeated infections with C. trachomatis is the recombinant chlamydial 
protease-like activity factor (rCPAF) (Murthy et al., 2011).This antigen has been reviewed as 
a potential vaccine candidate (Murthy et al., 2009) and has successfully induced a 
combination of neutralising antibodies and cell-mediated responses against genital 
chlamydial challenge in a murine model of genital chlamydial infection (Li et al., 2010).  
More recent studies have reported that mice vaccinated intranasally with rCPAF and the 
adjuvant CpG were significantly protected against infertility as seen by a reduction in 
hydrosaplinx in rCPAF+CpG vaccinated mice following a primary genital challenge with C. 
muridarum (Murthy et al.,, 2011). This latest finding augurs well for the inclusion of this 
candidate antigen in a vaccine for use in humans to protect against female infertility. 
Recently, a proteomics approach has been used to identify potential vaccine candidates for 
chlamydial infections. In one study three strains of mice, BALB/c, C3H/HeN and C57BL/6, 
were inoculated with live and inactivated C. muridarum by different routes of immunization. 
Using a protein microarray, serum samples collected from the mice after immunization were 
tested for the presence of antibodies against specific chlamydial antigens. This has identified 
a panel of seven C. muridarum dominant antigens (TC0052, TC0189, TC0582, TC0660, 
TC0726, TC0816 and, TC0828) (Molina, 2010).  In a second study by the same group antigen 
identification was done by constructing a protein chip array by expressing the open reading 
frames (ORFs) from C.muridarum genomic and plasmid DNA and testing it with serum 
samples from C.muridarum immunized mice. This second approach has resulted in the 
identification of several new immunogens, including 75 hypothetical proteins thus 
identifying a new group of immunodominant chlamydial proteins that can be tested for 
their ability to induce protection (Cruz-Fisher et al., 2011). 
4.5 Neisseria gonorrhoeae  
N. gonorrhoeae has been implicated in tubal infections. Both the bacteria themselves or 
components of the bacterial cell wall, lipopolysaccharide or peptidoglycan reportedly cause 
cessation of the ciliary activity (Mardh 1979) however, infection of the Fallopian tubes does 
not always result in ultrastructural damage to the mucosal surface (Woods & McGee 1986). 
Gonococci only invade the non-ciliated cells of the Fallopian tube mucosa, whereby the 
neighbouring ciliated cells become sloughy and detached (McGee 1981). Neisseria spp. 
infection of the Fallopian tubes results in a dose-dependent response to bacterial cells. Low 
numbers of bacterial cells induce secretion of TNF-ǂ and subsequently apoptosis of infected 
cells, however, when bacterial cell numbers increase, the apoptosis appears to be inhibited, 
favouring bacterial survival (Dean and Powers, 2001). Studies have suggested that ectopic 
pregnancy is now more likely to be associated with non-gonococcal rather than N. 
gonorrhoeae upper genital tract infection (Kamwendo et al., 1996). 
4.6 Mycoplasma species  
M. hominis reportedly causes ciliostasis and swelling of Fallopian tube cilia (Mardh & 
Westrom 1970). Mycoplasma spp. have been isolated from the female upper genital tract and 
Fallopian tubes (Cohen 2005; Heinonen & Miettinen 1994; Stagey et al 1992). Serological 
testing of women has confirmed an association between mycoplasmas and cases of PID 
(Moller et al., 1985)and mycoplasma, PID and ectopic pregnancy (Jurstrand et al., 2007). A 
prospective study of 212 infertile couples was undertaken to investigate the presence of 
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M.genitalium in women with tubal factor infertility and it was found that antibodies to 
M.genitalium were shown to be independently and significantly associated with tubal factor 
infertility (Svenstrup et al., 2008). 
Recently it has been reported that a genetic polymorphism in one of the components of the 
inflammasome - a cytoplasmic structure producing interleukin-1 - increases the likelihood of 
mycoplasma infection-associated female infertility (Witkin et al., 2010). 
4.7 Ureaplasma spp.  
Ureaplasma spp. have been implicated in infections of the lower (bacterial vaginosis) and of 
the upper genital tracts (PID, endometritis) of women (Kanakas et al 1999). Further, tubal 
infertility has been associated with ureaplasma PID in a small number of cases (Henry-
Suchet et al 1980. Inoculation of Ureaplasma spp. into in vivo Fallopian tube organ cultures 
resulted in replication of the pathogen, suggesting that this genital mycoplasma may also 
play a role in tubal damage. 
4.8 Anaerobic bacteria  
Anaerobic species are frequently isolated from the female genital tract and in cases of acute 
PID (Saini et al 2003). The polymicrobial nature of anaerobic infections appears to enhance 
the pathogenicity of the implicated species implicated (Eschenbach et al 1975). Previous 
upper genital tract pathology caused by upper genital tract infections, pelvic adhesions, 
endometriosis or prolonged or continuous menstruation, have been associated with the 
reactivation of PID. It is likely that the compromised areas of the pelvic cavity promote the 
establishment of a niche for bacterial survival (El-Shawarby et al 2004). Ness et al. (2005) 
reported that the presence of anaerobic bacterial vaginosis-associated microorganisms in the 
vagina was a significant risk factor for infection of the upper genital tract leading to long-
term sequelae and possible PID.  
Mobiluncus spp. are frequently isolated from women with bacterial vaginosis. Members of the 
Mobiluncus genera have been shown to produce cytotoxins, resulting in the loss of cilia, and 
bloating and detachment of the ciliated cells of the Fallopian tube mucosa (Taylor-Robinson et 
al 1993). Another of the genera associated with bacterial vaginosis, the gram-negative 
Bacteroides spp. also releases lipopolysaccharide, resulting in the sloughing of Fallopian tube 
epithelial cells and loss of ciliary activity within the Fallopian tubes (Fontaine et al 1986). 
4.9 Aerobic/Microaerophilic bacteria  
Gram-positive species, Enterococcus spp., Staphylococcus spp., and Streptococcus spp. have 
been isolated from Pouch of Douglas aspirates of a polymicrobial microflora in women with 
symptoms of genital tract infection (Saini et al 2003). Saini et al. (2003) proposed that the 
microflora of the Pouch of Douglas was likely to be more representative of Fallopian tube 
microorganisms in women with salpingitis than the vaginal flora of those same women. 
Members of the Enterbactereaceae have been detected in upper genital tract infections. The 
Gram-negative bacillus, Klebsiella spp. are frequently isolated from women with PID (Saini 
et al., 2003). Laufer et al.,. ((Laufer et al., 1984)) reported that inoculation of the Fallopian 
tubes with Escherichia coli resulted in complete de-ciliation or damage to the cilia. When 
damage occurred, the cilia were swollen and short. In addition, microvilli were lost from the 
non-ciliated cells. The oxidative species, Pseudomonas aeruginosa is also a causal agent of PID 
in females (King et al., 2002). 
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Based on previous studies, it has been concluded that genital tract infections including 
salpingitis, which causes tubal factor infertility are polymicrobial in nature. Furthermore, a 
diverse range of microorganisms are capable of colonising and possibly infecting the genital 
tract tissues. Opportunistic pathogens identified in genital tract infections are frequently 
members of the normal regional flora and should be further investigated given that 60% of 
PID is non-gonococcal and non-chlamydial. Infectious causes of salpingitis and tubal factor 
infertility require further investigation to better establish prevalence and causality. The 
identification of microorganisms that are particularly detrimental to the Fallopian tubes may 
result in effective treatment and a reduction in the overall frequency of tubal factor 
infertility and tubal ectopic pregnancy. 
5. Ectopic pregnancy and chlamydia 
Infectious agents cause damage to the Fallopian tube mucosa either directly or because of 
the host inflammatory response aimed at clearing the infection. Alteration to the mucosa can 
result in poor transport of the embryo and subsequent implantation of the blastocyst outside 
the endometrial lining of the uterine cavity – an ectopic pregnancy.   Tubal ectopic 
pregnancy is a result not only of impaired transport of the embryo causing the embryo to be 
maintained in the Fallopian tube but also a result from alterations in the tubal environment 
that allows early implantation to occur (reviewed in Shaw et al., 2010). A recent review also 
summarises the results of investigations of the Fallopian tube with respect to the roles of of 
caspase 1, cannabinoid receptor and Dicer 1 knockout mice and how these contribute to 
tubal dysfunction and contribute to ectopic pregnancies (Shao 2010). 
A recent review highlighted the many risk factors for ectopic pregnancy and these are 
summarised in Table 1. 
 




Previous ectopic pregnancy 
In utero exposure to diethylstilbestrol 





Previous genital infections 
Multiple sexual partners 
Salpingitis isthmica nodosa 
Low risk
Previous pelvic infection 
Cigarette smoking 
Vaginal douching 
First intercourse (<18 years) 
Table 1. Risk Factors for ectopic preganacy  (adapted from Kulp and Barnhart, 2008) 
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Ectopic pregnancy accounts for up to 11% of all pregnancies and there is serological 
evidence that links ectopic pregnancies with C. trachomatis infection in women (Chow et al., 
1990; Swenson & Schachter 1984) It was noted in one study that 19/21 C. trachomatis 
seropositive women with ectopic pregnancies had antibodies to the chlamydial 57kDa 
antigen and it was suggested that perhaps immune responses to this antigen may be 
involved in the immunopathogenesis of ectopic pregnancy associated with C. trachomatis 
infections (Brunham et al., 1992). A recent review has reported that one third of ectopic 
pregnancies could be attributable to chlamydial infection (Bebear and de Barbeyrac, 2009). 
The finding of chlamydial RNA in Fallopian tube biopsy samples collected from women 
with ectopic pregnancies suggested that viable, metabolically active bacteria were present in 
the Fallopian tubes of these women (Gerard et al., 1998). Chlamydial DNA has also been 
detected in the Fallopian tube tissue collected from women at the time of ectopic pregnancy 
(Barlow et al., 2001; Noguchi et al., 2002).  A report to the contrary regarding the detection of 
chlamydial DNA in fresh tissue from the Fallopian tubes of women with ectopic pregnancy 
has, however, also been published and suggested that persistent chlamydial infection of 
Fallopian tubes was rare in ectopic pregnancy (Bjartling et al., 2007). A retrospective study 
looking at births and ectopic pregnancy in 20, 762 women in Norway has reported that the 
risk of ectopic pregnancy increased in a dose-dependent manner with the increasing 
number of prior chlamydial infections (Bakken et al., 2007). In a comprehensive review by 
the same author it has been reported that relatively low risks of ectopic pregnancy are 
recorded after a positive C. trachomatis diagnosis with, in Sweden for example, a cumulative 
incidence before the age of 35 years of rates of 2.7% C. trachomatis-positive and 2% C. 
trachomatis-negative (Bakken 2008). 
In a small study of 14 ectopic pregnancy patients who were serologically-positive for C. 
trachomatis, subjective immunohistochemistry techniques were used to show an increase in 
the expression of inducible nitric oxide synthase (iNOS) (which is related to inflammation 
and infection and which can generate nitric oxide) and activin A (a member of the 
transforming growth factor beta family that has been reported to increase inflammation and 
repair) in Fallopian tubes from these women (Refaat et al., 2009). It was proposed by these 
authors that tubal activin A and nitric oxide (NO) could perhaps be involved in microbial–
mediated damaging immune response within the Fallopian tubes of Chlamydia-infected 
women and that their pathological expression may lead to ectopic pregnancy development 
(Refaat et al., 2009).  Nitric oxide is similarly proposed as the damaging agent of cells in the 
uterine tubes of female mice in the murine model of chlamydial genital infection.  It is 
proposed that nitric oxide expressed in  macrophages in response to a C. muridarum 
infection in mice could perhaps be the cause of damage to oviduct interstitial cells of Cajal 
(ICC-OVI) that have been identified as oviduct pacemaker cells critical for egg transport 
along the Fallopian tubes (Dixon et al., 2010). The expression of iNOS by human Fallopian 
tubes has recently been reported as being cyclical during different stages of the menstrual 
cycle and the intensity of expression of iNOS was found to be higher in the Fallopian tubes 
of 15 women bearing an ectopic pregnancy when compared with pseudo-pregnant women 
(Al-Azemi et al., 2010).  These results suggested that increased iNOS levels in response to a 
microbial infection could lead to an increased expression of nitric oxide which may in turn 
affect the contraction of muscles and/or the ciliary beat in Fallopian tubes, ultimately 
leading to retention of the embryo at this site. 
A recent report from The Netherlands has presented the finding that a peak incidence of 
admissions for PID in 1983 preceded a peak incidence of ectopic pregnancy in 1988 mainly 
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due to a decrease in ectopic pregnancy in women over 35 years of age. The report also states 
that women born between 1985 and 1990 and less than 25 years of age are now at an 
increased risk of ectopic pregnancy and this rise has not been preceded by a peak incidence 
of PID (Mol et al., 2010). These authors further conclude that the significant rise in ectopic 
pregnancies may in fact be related to an increase in positive tests for chlamydial infection of 
the genital tracts (Mol et al., 2010). 
The management of ectopic pregnancy has recently been addressed (Kulp & Barnhart 2008; 
Mol et al., 2011). 
6. Endometriosis and Fallopian tube function 
Women with endometriosis have an increased incidence of tubal ectopic pregnancy, 
suggesting that endometriosis results in impairment of tubal transport of gametes and 
embryos. Previous in vitro studies have revealed that peritoneal fluid collected from women 
with endometriosis caused a decrease in the Fallopian tube ciliary beat frequency (Lyons et 
al., 2006), which supports the increased incidence of implantation of the embryo within the 
Fallopian tubes of these women. The pelvic inflammation associated with endometriosis can 
also cause adhesion and scar tissue formation within the Fallopian tubes creating a physical 
obstruction to embryo transport (Halis & Arici 2004). The pathogenesis of endometriosis 
involves changes both in cellular and in humoral immunity. Impaired natural killer cell 
activity results in inadequate removal of debris following retrograde menstruation. Elevated 
primary inflammatory mediators, which are characterised by increased numbers of 
macrophages, result in the production of secondary inflammatory mediators such as 
cytokines, chemokines and growth factors (Harada et al., 2001) However, the secretion of 
primary inflammatory mediators can also be induced by microbial stimuli (Wira et al., 2005). 
This highlights the relevance of a non-sterile endometrium in this aetiology. It may be that 
the retrograde menstruation of colonised or contaminated (by microorganisms) menstrual 
blood enhances the pathology of endometriosis by recruiting macrophages, which then 
secrete elevated levels of pro-inflammatory cytokines. 
A small study investigating eutopic and ectopic endometrium, identified DNA with a 96% 
homology to the Gram-negative bacterium Shigella spp. in ectopic but not in eutopic 
endometrium. Therefore, an infection hypothesis was proposed for the pathogenesis of 
endometriosis (Kodati et al., 2008). Recently, Khan et al.,. (Khan et al., 2010) reported a 
significant increase in the number of colony forming units of E. coli recovered from the 
menstrual blood of women with endometriosis when compared to women without the 
disease. In their study, the bacterial endotoxin concentration was also higher both in the 
menstrual blood and in the peritoneal fluid samples from women with endometriosis. The 
relative level of E. coli within the peritoneal fluid of women with endometriosis was likely 
due to retrograde menstruation through the Fallopian tubes and into the pelvic cavity. The 
‘open’ nature of the female genital tract makes it unlikely that secretions from the uterus, 
Fallopian tubes and peritoneal cavity remain compartmentalised. Transport of 
microorganisms within the upper genital tract may well be an area requiring further 
investigation in the pathogenesis of endometriosis and its increased association with tubal 
ectopic pregnancy. 
Interestingly, E. coli has also been cultured from tubo-ovarian abscesses in women with 
ovarian endometriomas and pelvic endometriosis (Kavoussi et al., 2006; Lin et al., 2010).The 
fluid-filled ovarian endometrioma may provide an excellent growth medium for 
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microorganisms, and endometriomas have been identified as a risk factor for tubo-ovarian 
abscess formation (Kubota et al., 1997; Lin et al., 2010). Women with endometriosis appear to 
represent a population at increased risk of infection and subsequent tubo-ovarian abscess 
due to an altered local immune environment (Chen et al., 2004; Lebovic et al., 2001). The risk 
of endometriosis is also increased in women with shorter menstrual cycles and an increased 
menstrual flow (Halme et al., 1984). Again, the retrograde menstruation of non-sterile 
menstrual blood into the peritoneal cavity provides a route for microbial transport. The 
menstrual debris may also promote continued survival and persistence of these 
microorganisms in the upper genital tract. Microorganisms have been detected in the 
endometrium of 83% of women during the post-partum period (Andrews et al., 2005). 
However, both vaginal and endocervical cultures demonstrated low concordance with 
endometrial cultures (Cicinelli et al., 2009). This may suggest that tropisms exist in the 
genital tract that can modulate microbial survival. In studies investigating women with 
chronic endometritis, Cicinelli et al.,. (Cicinelli et al., 2008) reported isolation aerobic bacteria 
in over 73% of cases in symptomatic women but in only 5% of women without clinical 
evidence of endometritis. A shortcoming if their study was that they did not screen 
endometrial samples for the presence of anaerobes, which dominate the genital microflora. 
Together, these studies suggest that the endometrial cavity is not sterile, and that the 
presence of microorganisms does not necessarily result on overt inflammation. The 
possibility exists that in women with endometriosis, who have an impaired genital tract 
immune response, that (1) these microorganisms may replicate causing increased pathology, 
including tubal damage and (2) the microflora represent a stimulus for the enhanced 
chemotaxis of macrophages and the subsequent secretion of secondary inflammatory 
mediators identified in this condition.  
Other chemical mediators have also been investigated in women with endometriosis. 
Inducible nitric oxide synthase, activated by cytokines and growth factors (Morris and 
Billiard, 1994; Nussler and Billiar, 1993), regulates embryo transport within the Fallopian 
tube. What is interesting is that in women with endometriosis and PID, nitric oxide levels 
are increased (Alpay et al., 2006; Bouyer et al., 2002; Sioutas et al., 2008). Lipopolysaccharide 
was capable of in vitro activation of macrophages in the peritoneal fluid of women with 
endometriosis, increasing inducible nitric oxide synthase and nitric oxide production in 
these women but not in women without disease (Osborn et al., 2002). If endometriosis is part 
of an infectious condition, then these results may be evidence of the activity f polarised 
macrophages in this population. A macromolecular ovum capture inhibitor, causing 
formation of a membrane over the fimbrial cilia, has been also detected in the peritoneal 
fluid from women with endometriosis (Suginami & Yano 1988). 
Studies investigating ectopic pregnancy following IVF are limited however, it has been 
suggested that the hormonal stimulation protocol and the infertility history may also be 
mechanisms predisposing women to ectopic pregnancy (Chang & Suh 2010). 
7. IVF 
Hydrosalpinx is associated with decreased IVF success (Wainer et al., 1997). Approximately 
30% of women undergoing IVF for tubal factor infertility have hydrosalpinges (Blazar et al., 
1997; Murray 1997). The incidence of ectopic pregnancy was significantly higher in patients 
having IVF treatment for tubal factor infertility than in those diagnosed with infertility die 
to endometriosis or idiopathic infertility (Dubuisson et al., 1991). It has been reported that 
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there was no relationship between the ectopic pregnancy rate and the ovarian 
hyperstimulation protocol used for ovulation induction (Dubuisson et al., 1991). This is 
despite some studies suggesting that the hormonal protocols used in IVF contribute to 
ectopic pregnancy possibly by alterations in tubal muscle contractions or ciliary beat.  
The ectopic pregnancy rate for women having IVF with natural and stimulated cycles was 
around 11% (Dubuisson et al., 1991), this is consistent with previous reports (Yovich et al., 
1985) indicating that in infertile women undergoing IVF and embryo transfer, the rate of 
tubal ectopic pregnancy is significantly higher compared to women conceiving naturally. 
8. Conclusions 
Infectious agents can damage biological functions of the female reproductive tract with 
devastating consequences. Among the most common microorganisms involved in sexually 
transmitted infections and interfering with female fertility are C. trachomatis and N. 
gonorrhoeae. These two pathogens are involved in damage to the cervix, Fallopian tubes and 
tubal luminal architecture in infected women. Tubo-peritoneal damage seems to be the 
leading cause of microbial interference with human fertility. C. trachomatis is considered the 
most important cause of tubal obstruction and PID. Screening for repeat chlamydial 
infections using randomised control trials and prevalence of Chlamydia rather than PID as an 
end point should provide information useful for controlling morbidity associated with these 
infections.  Infection of the female genital tract with other bacterial organisms including M. 
genitalium, Ureaplasma spp., anaerobes and aerobes/microaerophiles can also affect the 
precise functioning of components of this site resulting in tubal occlusion and infertility. 
Bacterial vaginosis is strongly linked to tubal infertility as causative agents can produce 
ascending infections of the female upper genital tract. The role of bacterial infections 
particularly those caused by C. trachomatis and immune responses to these infections as 
causes of damage to sperm function require further investigation.  Finally, continued efforts 
in vaccine development to control C. trachomatis genital infections would seem prudent to 
prevent sequelae of unresolved or untreated infections of the female genital tract that can 
have profound effects on fertility in women. 
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